NeurAxis, Inc. (NYSE: NRXS) is a biotech company developing Neuromodulation Therapies to address chronic and debilitating conditions in kids. Read More
Sept. 26, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE: NRXS), a medical technology company commercializing neuromodulation
therapies that address chronic and debilitating conditions in children and adults, today announced the results of a retrospective comparative study of adolescent patients with functional abdominal pain disorders. Learn More
*This Feature Article & YouTube Video is SPONSORED CONTENT. We are expecting to be compensated as much as $10K USD via bank wire by a third party for the advertising / marketing of this publicly traded
company.
